Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study*

BACKGROUND: Protein-energy wasting (PEW) in end-stage renal disease (ESRD) patients is associated with increased morbidity and mortality, but options for treatment are limited. Growth hormone (GH) increases insulin-like growth factor 1 (IGF-1), with improved nutritional parameters, but must be given...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nephrol Dial Transplant
Hlavní autoři: Campbell, Garland A, Patrie, James T, Gaylinn, Bruce D, Thorner, Michael O, Bolton, Warren K
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019053/
https://ncbi.nlm.nih.gov/pubmed/28340044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw474
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky